Acadian Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,591
| Closed | -$156K | – | 1709 |
|
|
2024
Q3 | $156K | Buy |
+4,591
| New | +$156K | ﹤0.01% | 1450 |
|
|
2020
Q3 | – | Sell |
-228,015
| Closed | -$2.96M | – | 2192 |
|
|
2020
Q2 | $2.96M | Sell |
228,015
-70,634
| -24% | -$918K | 0.01% | 623 |
|
|
2020
Q1 | $496K | Buy |
298,649
+50,583
| +20% | +$84K | ﹤0.01% | 962 |
|
|
2019
Q4 | $553K | Sell |
248,066
-8,242
| -3% | -$18.4K | ﹤0.01% | 1046 |
|
|
2019
Q3 | $547K | Sell |
256,308
-11,249
| -4% | -$24K | ﹤0.01% | 1062 |
|
|
2019
Q2 | $718K | Buy |
267,557
+120,519
| +82% | +$323K | ﹤0.01% | 899 |
|
|
2019
Q1 | $723K | Buy |
147,038
+55,480
| +61% | +$273K | ﹤0.01% | 1007 |
|
|
2018
Q4 | $272K | Buy |
91,558
+19,152
| +26% | +$56.9K | ﹤0.01% | 1051 |
|
|
2018
Q3 | $490K | Sell |
72,406
-4,786
| -6% | -$32.4K | ﹤0.01% | 884 |
|
|
2018
Q2 | $583K | Buy |
77,192
+61,058
| +378% | +$461K | ﹤0.01% | 859 |
|
|
2018
Q1 | $563K | Buy |
+16,134
| New | +$563K | ﹤0.01% | 833 |
|